Skip to main content
SpringerLink
Log in

Carvedilol effective for cardiotoxicity prevention?

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. Carvedilol Effect in Preventing Chemotherapy Induced Cardiotoxicity (CECCY) trial; NCT01724450

Reference

  • Avila MS, et al. Carvedilol for Prevention of Chemotherapy Related Cardiotoxicity. Journal of the American College of Cardiology : 11 Mar 2018. Available from: URL: http://dx.doi.org/10.1016/j.jacc.2018.02.049

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Carvedilol effective for cardiotoxicity prevention?. Reactions Weekly 1694, 7 (2018). https://doi.org/10.1007/s40278-018-43409-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-43409-z

Search

Navigation